首页|右美托咪定联用青蒿琥酯调控PERK/ATF4/CHOP信号通路对缺血再灌注肺损伤大鼠的保护作用

右美托咪定联用青蒿琥酯调控PERK/ATF4/CHOP信号通路对缺血再灌注肺损伤大鼠的保护作用

扫码查看
目的:探究右美托咪定(Dex)联合青蒿琥酯(ART)对缺血再灌注肺损伤大鼠的保护作用及其调控机制.方法:60只SD大鼠随机分为假手术(Sham)组、模型对照组、Dex组(30 μg/kg)、ART组(100 mg/kg)、联合用药组(30 μg/kg Dex+100 mg/kg ART)、尼莫地平组(200 mg/kg),每组10只.除Sham组外其余5组建立缺血再灌注肺损伤(IR)模型,Sham组只开胸不结扎.实验结束后取动脉血检测动脉血气指标:二氧化碳分压(PaCO2)和氧分压(PaO2);试剂盒检测肺组织氧化还原指标超氧化物歧化酶(SOD)、丙二醛(MDA)、髓过氧化酶(MPO)以及肺组织和血清炎性因子肿瘤坏死因子α(TNF-α)、白细胞介素(IL)-1β、IL-18水平;HE检测肺组织的病理学变化以及TUNEL染色检测细胞凋亡情况;Western Blot法检测肺组织中内质网应激信号通路蛋白激酶R样内质网激酶(PERK)、活化转录因子4(ATF4)、CCAAT/增强子结合蛋白同源蛋白(CHOP)通路相关蛋白的表达.结果:与Sham组比较,模型对照组细胞凋亡率、PaCO2 及MDA含量、MPO活性、TNF-α、IL-1β、IL-18 含量及PERK、ATF4、CHOP蛋白表达升高,PaO2、SOD活性明显下降(P<0.05).与模型组比较,ART组、Dex组、联合用药组及尼莫地平组细胞凋亡率、PaCO2、MDA含量、MPO活性、TNF-α、IL-1β、IL-18含量、PERK、ATF4、CHOP表达降低,PaO2、血清SOD活性升高,且联合用药组上述指标的改变优于单一用药(P<0.05).结论:Dex联合ART能够保护IR大鼠缺血再灌注肺损伤,可能通过抑制PERK/ATF4/CHOP信号通路而实现.
Protective effect of dexmedetomidine combined with artesunate modulation of PERK/ATF4/CHOP signaling pathway in ischemia-reperfusion lung injury rats
Objective:To explore the protective effect of dexmedetomidine(Dex)combined with artesunate(ART)on ischemia-reperfusion lung injury in rats and its regulatory mechanism.Methods:A total of sixty SD rats were randomly divided into Sham operation group,model control group,ART(100 mg/kg),Dex(30 μg/kg),combination(30 μg/kg Dex+100 mg/kg ART),and nimodipine groups(200 mg/kg),with 10 rats in each group.Except for the Sham group,the rats in the remaining five groups were established in the ischemia-reperfusion lung injury model.The Sham group only opened the chest without ligation.After the experiment,the arterial blood was taken to detect the arterial blood gas indicators:Carbon dioxide partial pressure(PaCO2)and oxygen partial pressure(PaO2);The kits were used to detect the redox indicators malondialdehyde(MDA),superoxide dismutase(SOD)and myeloperoxidase(MPO)in lung tissue,and the levels of inflammatory factors tumor necrosis factor-α(TNF-α),interleukin(IL)-1β,and IL-18 in serum and lung tissue;Hematoxylin-eosin staining was used to detect the pathological changes of lung tissue;TUNEL staining was used to detect cell apopto-sis;Western Blot method was used to detect the expression of PERK/ATF4/CHOP pathway-related proteins in lung tissue.Results:Compared with those in the Sham group,PaCO2 and MDA content,MPO activity,the contents of TNF-α,IL-1β,and IL-18,and the expression of PERK,ATF4,CHOP protein were significantly increased,the PaO2,serum SOD activity were reduced in the model control group(P<0.05).Compared with those in the model group,the apoptosis rate,PaCO2 and MDA content,MPO activity,the contents of TNF-α,IL-1β,IL-18,and the expression of PERK,ATF4,CHOP proteins were reduced in the ART group,Dex group,combination group and ni-modipine group,the PaO2 and SOD activity were increased,and the changes of above indexes in the combination group were better than those in the monotherapy group(P<0.05).Conclusion:Dex combined with ART can protect rat ischemia-reperfusion lung injury,possibly by inhibiting the PERK/ATF4/CHOP signaling pathway.

DexmedetomidineLung Ischemia-Reperfusion InjuryLung InjuryIron DeathArtesunate

徐乾、梁威、李鹏、彭晓红、余丹

展开 >

武汉市第四医院麻醉科 湖北 武汉 430035

右美托咪定 肺缺血再灌注 肺损伤 铁死亡 青蒿琥酯

2024

武汉大学学报(医学版)
武汉大学

武汉大学学报(医学版)

CSTPCD
影响因子:0.959
ISSN:1671-8852
年,卷(期):2024.45(11)